| Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months | Journal of Thrombosis and Haemostasis | 2006 | 342 |
| Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation | Haematologica | 2006 | 154 |
| Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe | Bone Marrow Transplantation | 2006 | 153 |
| Pharmacogenetics of cyclophosphamide in patients with hematological malignancies | European Journal of Pharmaceutical Sciences | 2006 | 94 |
| A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life | Cancer | 2006 | 85 |
| Myeloablative and immunosuppressive properties of treosulfan in mice | Experimental Hematology | 2006 | 67 |
| Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival | Leukemia | 2006 | 63 |
| Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases | Vaccine | 2006 | 59 |
| Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation | Molecular and Cellular Biology | 2006 | 54 |
| Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center | Transplantation | 2006 | 51 |
| Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation | Journal of Clinical Microbiology | 2006 | 50 |
| T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil | Cancer Immunology, Immunotherapy | 2006 | 46 |
| Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysis | British Journal of Cancer | 2006 | 42 |
| The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies | Haematologica | 2006 | 41 |
| Strategies in the management of alemtuzumab-related side effects | Seminars in Oncology | 2006 | 39 |
| Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis | Journal of Thrombosis and Haemostasis | 2006 | 39 |
| A novel Bcr-Abl splice isoform is associated with the L248V mutation in CML patients with acquired resistance to imatinib | Leukemia | 2006 | 38 |
| Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation | Leukemia | 2006 | 35 |
| Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor | International Journal of Cancer | 2006 | 32 |
| Early mitochondrial alterations in ATRA-induced cell death | Cell Death and Differentiation | 2006 | 31 |
| Allogeneic haematopoietic stem cell transplantation: current status and future outlook | British Medical Bulletin | 2006 | 28 |
| Nucleostemin mRNA is expressed in both normal and malignant renal tissues | British Journal of Cancer | 2006 | 26 |
| Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes | Leukemia Research | 2006 | 26 |
| An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency | Haemophilia | 2006 | 25 |
| Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice | Leukemia | 2006 | 24 |
